Abstract

BackgroundUrtica dioica, Taraxacum officinale, Calea integrifolia and Caesalpinia pulcherrima are widely used all over the world for treatment of different illnesses. In Mexico, these plants are traditionally used to alleviate or counteract rheumatism and inflammatory muscle diseases. In the present study we evaluated the activity of aqueous and methanolic extracts of these four plants, on the replication of dengue virus serotype 2 (DENV2).MethodsExtraction process was carried out in a Soxtherm® system at 60, 85 and 120 °C; a chemical fractionation in silica gel chromatography was performed and compounds present in the active fractions were identified by HPLC-DAD-ESI/MSn. The cytotoxic concentration and the inhibitory effect of extracts or fractions on the DENV2 replication were analyzed in the BHK-21 cell line (plaque forming assay). The half maximal inhibitory concentration (IC50) and the selectivity index (SI) were calculated for the extracts and fractions.ResultsThe methanolic extracts at 60 °C of T. officinale and U. dioica showed the higher inhibitory effects on DENV2 replication. After the chemical fractionation, the higher activity fraction was found for U. dioica and T. officinale, presenting IC50 values of 165.7 ± 3.85 and 126.1 ± 2.80 μg/ml, respectively; SI values were 5.59 and 6.01 for each fraction. The compounds present in T. officinale, were luteolin and caffeoylquinic acids derivatives and quercertin diclycosides. The compounds in the active fraction of U. dioica, were, chlorogenic acid, quercertin derivatives and flavonol glycosides (quercetin and kaempferol).ConclusionsTwo fractions from U. dioica and T. officinale methanolic extracts with anti-dengue activity were found. The compounds present in both fractions were identified, several recognized molecules have demonstrated activity against other viral species. Subsequent biological analysis of the molecules, alone or in combination, contained in the extracts will be carried out to develop therapeutics against DENV2.

Highlights

  • Urtica dioica, Taraxacum officinale, Calea integrifolia and Caesalpinia pulcherrima are widely used all over the world for treatment of different illnesses

  • The aqueous extract with higher activity against Dengue virus (DENV) was obtained for T. officinale at 60 °C, which caused 53% inhibition at the maximum tested concentration (200 μg/mL)

  • None of the other extracts decreased more than 50% the number of lytic plaques produced by the virus

Read more

Summary

Introduction

Taraxacum officinale, Calea integrifolia and Caesalpinia pulcherrima are widely used all over the world for treatment of different illnesses. In the present study we evaluated the activity of aqueous and methanolic extracts of these four plants, on the replication of dengue virus serotype 2 (DENV2). Dengue fever is a viral disease transmitted by mosquitoes in the genus Aedes, the principal species are A. aegypti and A. albopictus. There are no specific antiviral compounds for the treatment, several research groups have sought antiviral compounds by molecular docking [5, 6] or using medicinal plants to inhibit a viral target [7, 8]. Having no specific antiviral therapy or an antiviral agent for dengue treatment, different methods for prevention have been established by controlling the mosquito reproduction or spread [10, 11]. Due to the lack of new molecules, some clinical researches have proposed the repurposing of well-known drugs such as chloroquine, prednisolone, balapiravir, celgosivir, and lovastatin, those drugs are safe, they have not been successful at decreasing viral load, antigenemia, fever or inducing a beneficial effect to dengue patients [12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call